ClinicalTrials.gg
CompletedNCT06966596Updated May 22, 2025

Low-Dose Ketamine Infusion for Post-Operative Pain in Patients Undergoing Laparoscopic Cholecyctectomy

A Phase 1 interventional study of Ketamine only and Placebo Normal Saline (NS) in Laparoscopic Cholecystectomy, sponsored by Fazaia Ruth Pfau Medical College. Completed at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Fazaia Ruth Pfau Medical College · Phase 1, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2024, registered May 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1
Study type
Interventional
Enrollment
116
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Cholelithiasis with a site in Pakistan — 2 open to participants now, 2 under way, none of them phase 3. Cholelithiasis · Pakistan.

Enrollment
4th of 12
116 · median 80
Started
2024
with 2 others
Phase 1
Only one
of the 12
Registered
4th of 12
by date
Lead sponsor
2 of 12
Fazaia Ruth Pfau Medical College

Among the 12 studies in Cholelithiasis with a site in Pakistan, this one is the 4th largest by enrollment, is one of 3 that started in 2024, is the only one in phase 1, and was the 4th registered.

Cholelithiasis

192 studies on the registry are indexed under Cholelithiasis; 44 are open to participants now.

Browse Cholelithiasis studies →

Open to participants now

2 of the 12 studies in Cholelithiasis with a site in Pakistan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 30 Cholelithiasis studies recruiting now, 20 (67%) set no upper age limit and 7 (23%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Cholelithiasis with a site in Pakistan, or all of them as a file.
02

Study summary

Following surgery, acute pain is a typical issue with a variety of implications. Surgeons, anesthesia specialists, and patients all desire effective pain management with the fewest possible adverse effects. At low dosages (\<0.3 mg/kg/hr) and large doses (>1 mg/kg), ketamine is utilized as an analgesic and an anaesthetic. Ketamine at high dosages causes dissociative anaesthesia with little impact on breathing or airway reflexes. Although this medication is a powerful analgesic, its usage is restricted due to it leads to agitation and hallucinations during awakening. Nevertheless, it has a potent analgesic effect when administered at a subanesthetic dose, and ketamine's psychomimetic side effects are rare at these dosages. This study intended to examine the role of low-dose for post-operative pain control in patients undergoing LC, despite the fact that numerous studies have been conducted on the subject and that the results have been inconsistent.

Read the detailed description

Most patients still stay overnight after a laparoscopic cholecystectomy (LC) due to post-operative pain, which continues to be the principal obstacle to early patient discharge. On the first postoperative day following laparoscopic procedures, patients may have mild to moderate postoperative pain, with decreased pain intensity in the shoulder area (from the subdiaphragmatic region), particularly intra-abdominal and local discomfort at the incision site. Because of its analgesic properties and cardiovascular stability, ketamine has been used extensively in anesthesia practice. It non-competitively blocks N-methyl-D-aspartate (NMDA) receptors. As an addition to multimodal perioperative pain management, ketamine has grown in favor in recent years. Ketamine at high dosages causes dissociative anaesthesia with little impact on breathing or airway reflexes. In a range of surgical procedures, low-dose ketamine infusions (\<0.3 mg/kg/hr) have demonstrated effectiveness in lowering pain scores and minimising the need for postoperative opioids. Regarding the reduction of pain and analgesic demand, ketamine has demonstrated conflicting effects. The study objective was to determine the effect of low-dose ketamine infusion on quality and duration of post-operative pain in patients undergoing laparoscopic in a tertiary care hospital.

03

Conditions studied

  • Laparoscopic Cholecystectomy

Browse trials for

Keywords

  • Cholelithiasis
  • Cholecystectomy
  • Laparoscopic surgery
  • Ketamine
  • Analgesia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of age 18 years or above of either gender
  • Patients planned of elective laparoscopic choleycyctectomy

Exclusion criteria

Exclusion Criteria:

  • Obese patients
  • History of alcohol consumption and drug abusers
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Patients with chronic pain
  • Patients allergic to study drugs
  • Patients with neurological disorders
  • Patients unable to understand scoring system
05

Study design

Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
116 participants (actual)

Study arms

  • Experimental
    Group A received ketamineat 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.

    Group A received ketamineat 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.2mg/kg/hr throughout the surgery.

    Drug: Ketamine only

  • Placebo comparator
    Control Group B

    Control group received normal saline intravenously at an equivalent infusion rate

    Other: Placebo Normal Saline (NS)

Interventions

  • DrugKetamineStudies of KetamineKetamine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Group A received ketamineat 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.2mg/kg/hr throughout the surgery. W

  • OtherPlacebo Normal Saline (NS)

    Control group received normal saline to maintain double blinding

06

What researchers measure

Primary outcomes

  1. Post-pain assessment

    pain was assessed using numeric rating scale which is a ten point scoring scale ranging from 0-10 for ranking pain where 0 means no pain and 10 means worst pain.

    Time frame: pain status was monitored post-operatively at 0 hour, 2 hour, 4 hours, 6 hours, 12 hours and at 24 hours

Secondary outcomes

  1. time to rescue analgesia

    time to rescue analgesia was defined as time point at which patient was given rescue analgesia for pain score of 5 or above

    Time frame: till 24 hours post-operatively

07

Study locations

1 site
  • Fazaia Ruth Pfau Medical College, PAF Hospital Base Faisal
    Karachi, Pakistan
08

References and documents

Publications

  • Jain S, Nazir N, Mustafi SM. Preemptive low-dose intravenous ketamine in the management of acute and chronic postoperative pain following laparoscopic cholecystectomy: a prospective randomized control study. Med Gas Res. 2022 Oct-Dec;12(4):141-145. doi: 10.4103/2045-9912.337995. PubMed 35435425 ↗
  • Akturk R, Serinsoz S. Determining a Method to Minimize Pain After Laparoscopic Cholecystectomy Surgery. Surg Laparosc Endosc Percutan Tech. 2022 Aug 1;32(4):441-448. doi: 10.1097/SLE.0000000000001071. PubMed 35797664 ↗
  • Gin E, Lowen D, Tacey M, Hodgson R. Reduced Laparoscopic Intra-abdominal Pressure During Laparoscopic Cholecystectomy and Its Effect on Post-operative Pain: a Double-Blinded Randomised Control Trial. J Gastrointest Surg. 2021 Nov;25(11):2806-2813. doi: 10.1007/s11605-021-04919-0. Epub 2021 Feb 9. PubMed 33565010 ↗

Individual participant data

Plan to share: No — This is institutional data which has to be concealed for patient's privacy

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2024 to primary completion in Mar 2025, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2025
First posted
May 13, 2025
StartActual
Nov 1, 2024
Primary completionActual
Mar 31, 2025
CompletionActual
Mar 31, 2025
Last update
May 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06966596
Lead sponsor
Fazaia Ruth Pfau Medical College
Responsible party
Syeda Hajrah Rehman (Principal Investigator, Fazaia Ruth Pfau Medical College) — Principal investigator
First posted
May 13, 2025
Start date
Nov 1, 2024
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025
Last update
May 22, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ketamine

Start the discussion